Impact of Safety Concerns and Regulatory Changes on the Usage of Erythropoiesis-Stimulating Agents and RBC Transfusions

Abstract

The impact of regulatory restrictions of erythropoiesis-stimulating agents (ESAs) on their use and on RBC transfusions was examined. A multivariate logistic regression showed a significant decline in ESA use without an increase in RBC transfusions

Similar works

Full text

thumbnail-image
oai:pubmedcentral.nih.gov:3227922Last time updated on 7/8/2012

This paper was published in PubMed Central.

Having an issue?

Is data on this page outdated, violates copyrights or anything else? Report the problem now and we will take corresponding actions after reviewing your request.